skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis

Oncotarget, 2018-02, Vol.9 (15), p.12351-12364

Copyright: © 2018 Peng et al. 2018 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.24033 ;PMID: 29552316

Full text available

Citations Cited by
  • Title:
    Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis
  • Author: Peng, Xingchun ; Shi, Jun ; Sun, Wanqun ; Ruan, Xuzhi ; Guo, Yang ; Zhao, Lunhua ; Wang, Jue ; Li, Bin
  • Subjects: Meta-Analysis
  • Is Part Of: Oncotarget, 2018-02, Vol.9 (15), p.12351-12364
  • Description: IL-6 is critical for tumorigenesis. However, previous studies on the association of IL-6 promoter polymorphisms with predisposition to different cancer types are somewhat contradictory. Therefore, we performed this meta-analysis regarding the relationship between IL-6 promoter single nucleotide polymorphisms and cancer susceptibility and prognosis. Up to April 2017, 97 original publications were identified covering three IL-6 promoter SNPs. Our results showed statistically significant association between IL-6 promoter and cancer risk and prognosis. Subgroup analysis indicated that rs1800795 was significantly associated with increased risk of cervical cancer, colorectal cancer, breast cancer, prostate cancer, lung cancer, glioma, non-Hodgkin's lymphoma and Hodgkin's lymphoma but not gastric cancer and multiple myeloma. Furthermore, rs1800796 was significantly associated with increased risk of lung cancer, prostate cancer and colorectal cancer but not gastric cancer. Additionally, rs1800797 was significantly association with breast cancer, non-Hodgkin's lymphoma, B-cell lymphoma and diffuse large B-cell lymphoma but not gastric cancer. Simultaneously, rs1800795 and rs1800796 were associated with a significantly higher risk of cancer in Asia and Caucasian, rs1800797 was associated with a significantly risk of cancer in Caucasian but not in Asia. Furthermore, IL-6 promoter polymorphisms were significantly associated with the prognosis of cancer. Considering these promising results, IL-6 promoter including rs1800795, rs1800796 and rs1800797 may be a tumor marker for cancer therapy.
  • Publisher: United States: Impact Journals LLC
  • Language: English
  • Identifier: ISSN: 1949-2553
    EISSN: 1949-2553
    DOI: 10.18632/oncotarget.24033
    PMID: 29552316
  • Source: GFMER Free Medical Journals
    PubMed Central
    Alma/SFX Local Collection
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait